Delivery Order SPE2DB20D9127-SPE2DB23FPRL2
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract award of $49,531.40 is for the delivery of 3,750 units of the oncology medication ONCASPAR 3,750 UNIT/5 ML VIAL 5ML. The contract is a firm fixed-price delivery order that does not have a set-aside designation. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $82,930.72, is for the delivery of 3,750 units of the pharmaceutical product ONCASPAR 3,750 UNIT/5 ML VIAL 5ML. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $49,531.40 firm fixed-price delivery order is for the supply of 4,566,744,841 units of the oncology medication ONCASPAR 3,750 UNIT/5 ML VIAL 5ML. This award is made under DMS Pharmaceutical Group's $499,999,999 Indefinite Delivery Contract (IDC) with the DLA, which enables the agency to issue...
- This is a firm fixed-price delivery order for $54,702.90 awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for 3,750 units of the prescription drug ONCASPAR 3,750 UNIT/5 ML VIAL 5ML and has a period of performance through February 27, 2025. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $49,531.40 firm fixed-price delivery order is for the supply of 3,750 units of the drug ONCASPAR in 5 ml vials to support the recurring medical supply needs of military healthcare facilities. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $124,396.08 firm fixed-price delivery order is for the supply of 4,554,408,511 units of the oncology drug ONCASPAR (3,750 unit/5 mL vial, 5 mL) to support the recurring medical supply needs of military health facilities. This delivery order is part of a larger $499,999,999 indefinite delivery...
- This federal contract award, valued at $82,930.72, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4,555,565,043 units of the oncology drug ONCASPAR in 5 ml vials. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs through December...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $86,440.56, is for the delivery of 3,750 units of the oncology medication ONCASPAR in 5 mL vials. The contract has an ultimate completion date of March 16, 2022 and is not associated with any set-aside designation. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $82,930.72 delivery order is for 3,750 units of the oncology medication ONCASPAR in 5 ML vials. The award is under a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 between DMS Pharmaceutical Group and the DLA, which enables the DLA to issue delivery orders for a comprehensive...
- This federal contract award, valued at $86,440.56, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of 4,557,549,804 units of the oncology medication ONCASPAR in 5 ML vials. DMS Pharmaceutical Group Inc. holds a single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at...
- SPE2DB20D9127Indefinite Delivery Contract
- SPE2DB20D9127-SPE2DB23FPRL2Delivery Order
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $49,531.40 contract is for the delivery of 4,562 units of the oncology drug ONCASPAR (3,750 units/5 ml vial) to support the medical supply needs of military healthcare facilities. The award is not associated with a set-aside designation. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. This IDC positions DMS Pharmaceutical Group as a crucial supplier in the federal pharmaceutical supply chain, providing direct distribution of prescription drugs and pharmacy services to Department of Defense healthcare sites.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $49.5k | 8/28/23 |